Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children.


Abstract

We have identified multiple genetic variants in SLC28A3 and other genes associated with ACT. Combined with clinical risk factors, genetic risk profiling might be used to identify high-risk patients who can then be provided with safer treatment options.


Full Text

  • DOI - Journal of clinical oncology : official journal of the American Society of Clinical Oncology (DOI)
  • HighWire Press - full-text online
  • EBSCO - full-text online

Subjects


Similar articles

Español | English

© Galenicom 1999-2013